{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:47:42Z","timestamp":1791190062357,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2013R1A1A3010109"],"award-info":[{"award-number":["NRF-2013R1A1A3010109"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korean government (MEST)","award":["2012028788"],"award-info":[{"award-number":["2012028788"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.anl.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T05:20:44Z","timestamp":1432876844000},"page":"472-477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Prognostic factors and outcome analysis of salivary duct carcinoma"],"prefix":"10.1016","volume":"42","author":[{"given":"Myung Woul","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Lyel","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Yuhl","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Ja","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2015.04.005_bib0170","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/1097-0142(19930901)72:5<1503::AID-CNCR2820720503>3.0.CO;2-K","article-title":"Salivary duct carcinoma","volume":"72","author":"Delgado","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.anl.2015.04.005_bib0175","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1097-0347(199703)19:2<126::AID-HED7>3.0.CO;2-6","article-title":"Salivary duct carcinoma: clinical characteristics and treatment strategies","volume":"19","author":"Guzzo","year":"1997","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2015.04.005_bib0180","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0194-59980301386-X","article-title":"Salivary duct carcinoma","volume":"129","author":"Hosal","year":"2003","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2015.04.005_bib0185","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/jso.21045","article-title":"Prognostic values of pathologic findings and hypoxia markers in 21 patients with salivary duct carcinoma","volume":"97","author":"Roh","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.anl.2015.04.005_bib0190","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ijrobp.2010.09.042","article-title":"Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy","volume":"82","author":"Schoenfeld","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.anl.2015.04.005_bib0195","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/archoto.2009.70","article-title":"Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma","volume":"135","author":"Tanvetyanon","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2015.04.005_bib0200","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ijrobp.2010.09.042","article-title":"Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy","volume":"82","author":"Schoenfeld","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.anl.2015.04.005_bib0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1758-3284-3-31","article-title":"Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies","volume":"3","author":"Pederson","year":"2011","journal-title":"Head Neck Oncol"},{"key":"10.1016\/j.anl.2015.04.005_bib0210","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/jcp.56.12.914","article-title":"Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour","volume":"56","author":"Etges","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anl.2015.04.005_bib0215","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cncr.9050","article-title":"Salivary duct carcinoma: cytologic characteristics and application of androgen receptor immunostaining for diagnosis","volume":"93","author":"Moriki","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.anl.2015.04.005_bib0220","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1200\/JCO.2009.25.4011","article-title":"Emerging targeted therapies for breast cancer","volume":"28","author":"Alvarez","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2015.04.005_bib0225","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0030-4220(94)90120-1","article-title":"Salivary duct carcinoma. Part II. Immunohistochemical evaluation of 13 cases for estrogen and progesterone receptors, cathepsin D, and c-erbB-2 protein","volume":"78","author":"Barnes","year":"1994","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.anl.2015.04.005_bib0230","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2559.2008.03159.x","article-title":"Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas","volume":"53","author":"Ettl","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.anl.2015.04.005_bib0235","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/00313020802040659","article-title":"The use of immunohistochemistry in the diagnosis of primary salivary duct carcinoma: three case reports","volume":"40","author":"Leecy","year":"2008","journal-title":"Pathology"},{"key":"10.1016\/j.anl.2015.04.005_bib0240","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hed.20614","article-title":"Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy","volume":"29","author":"Nabili","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2015.04.005_bib0245","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1078\/0344-0338-00136","article-title":"Salivary duct carcinoma \u2013 a highly aggressive salivary gland tumor with HER-2\/neu oncoprotein overexpression","volume":"197","author":"Skalova","year":"2001","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.anl.2015.04.005_bib0250","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/PAS.0b013e3180caa099","article-title":"Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients","volume":"31","author":"Williams","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anl.2015.04.005_bib0255","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1158\/1078-0432.CCR-09-0238","article-title":"Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance","volume":"16","author":"Williams","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anl.2015.04.005_bib0260","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archotol.133.10.1031","article-title":"Amplification and overexpression of HER2\/neu gene and HER2\/neu protein in salivary duct carcinoma of the parotid gland","volume":"133","author":"Cornolti","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2015.04.005_bib0265","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1600-0714.2009.00770.x","article-title":"Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours","volume":"38","author":"Monteiro","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.anl.2015.04.005_bib0270","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.seminoncol.2008.03.009","article-title":"Salivary gland malignancies: the role for chemotherapy and molecular targeted agents","volume":"35","author":"Surakanti","year":"2008","journal-title":"Semin Oncol"},{"key":"10.1016\/j.anl.2015.04.005_bib0275","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.oraloncology.2008.07.010","article-title":"Cetuximab in recurrent and\/or metastatic salivary gland carcinomas: a phase II study","volume":"45","author":"Locati","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.anl.2015.04.005_bib0280","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1200\/JCO.2007.11.8612","article-title":"Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and\/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands","volume":"25","author":"Agulnik","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2015.04.005_bib0285","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1586\/14737140.8.4.645","article-title":"Salivary gland cancers: current treatments, molecular characteristics and new therapies","volume":"8","author":"Chandana","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.anl.2015.04.005_bib0290","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/hed.20714","article-title":"Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy","volume":"30","author":"Prat","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2015.04.005_bib0295","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1200\/JCO.2011.36.2095","article-title":"Salivary duct carcinoma: targeting the phosphatidylinositol 3-kinase pathway by blocking mammalian target of rapamycin with temsirolimus","volume":"29","author":"Piha-Paul","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2015.04.005_bib0300","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1017\/S0022215108002314","article-title":"Biological therapy of salivary duct carcinoma","volume":"123","author":"Nashed","year":"2009","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.anl.2015.04.005_bib0305","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1002\/cncr.21116","article-title":"Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases","volume":"103","author":"Jaehne","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.anl.2015.04.005_bib0310","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/PAT.0b013e3283484a60","article-title":"Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas","volume":"43","author":"Clauditz","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.anl.2015.04.005_bib0315","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.joms.2007.05.024","article-title":"Salivary duct carcinoma of the parotid gland: case report and review of the literature","volume":"66","author":"Jamal","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"issue":"Suppl. 7","key":"10.1016\/j.anl.2015.04.005_bib0320","doi-asserted-by":"crossref","first-page":"vii36","DOI":"10.1093\/annonc\/mdq421","article-title":"Treatment of HER2-overexpressing breast cancer","volume":"21","author":"Baselga","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anl.2015.04.005_bib0325","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nrclinonc.2009.216","article-title":"Molecular predictors of response to trastuzumab and lapatinib in breast cancer","volume":"7","author":"Esteva","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.anl.2015.04.005_bib0330","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.semcdb.2010.08.009","article-title":"EGFR signaling in breast cancer: bad to the bone","volume":"21","author":"Foley","year":"2010","journal-title":"Semin Cell Dev Biol"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038581461500125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038581461500125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:31:32Z","timestamp":1759951892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S038581461500125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S038581461500125X"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2015.04.005","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors and outcome analysis of salivary duct carcinoma","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}